XOM Stock Analysis: Exxon Mobil | NYSE
Oil & Gas Integrated | NYSE, USA | Market Cap: 568.231m USD | 12M Return: 24.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.45B
EPS Trend: -96.0%
Qual. Beats: 1
Rev. Trend: -79.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Exxon Mobil Corporation (NYSE: XOM) is an integrated oil and gas company headquartered in Spring, Texas, founded in 1870. The company operates through four segments: Upstream (exploration and production of crude oil and natural gas in the U.S., Canada, and internationally), Energy Products (fuels, aromatics, catalysts, and licensing services), Chemical Products (olefins, polyolefins, and intermediates), and Specialty Products (lubricants, basestocks, waxes, synthetics, elastomers, and resins). Beyond its core operations, Exxon Mobil is also involved in the manufacture, trade, transport, and sale of crude oil, natural gas, petroleum products, and petrochemicals, and sells its products under the Exxon, Esso, and Mobil brands.
The company is also pursuing lower-emission and emerging business opportunities, including carbon capture and storage (CCS), hydrogen, lower-emission fuels, its Proxxima resin systems, carbon materials, low-carbon data center solutions, and lithium, and it supplies aviation fuel. As a mega-cap member of the Integrated Oil & Gas sub-industry, Exxon Mobil participates across nearly the entire hydrocarbon value chain, from upstream extraction through midstream logistics, downstream refining and chemicals, and increasingly into energy transition technologies that have become a focal area for major oil majors as they adapt to evolving energy markets.
- Brent crude prices rally on tight supply outlook
- Refining margins widen on resilient product demand
- Permian and Guyana production growth drives upstream volumes
| Net Income: 25.3b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.19 > 1.0 |
| NWC/Revenue: 1.05% < 20% (prev 5.12%; Δ -4.07% < -1%) |
| CFO/TA 0.10 > 3% & CFO 47.7b > Net Income 25.3b |
| Net Debt (45.5b) to EBITDA (60.4b): 0.75 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.18b) vs 12m ago -6.25% < -2% |
| Gross Margin: 25.49% > 18% (prev 22.45%; Δ 3.04% > 0.5%) |
| Asset Turnover: 71.16% > 50% (prev 75.21%; Δ -4.06% > 0%) |
| Interest Coverage Ratio: 48.16 > 6 (EBIT TTM 33.4b / Interest Expense TTM 693.0m) |
| A: 0.01 (Total Current Assets 97.8b - Total Current Liabilities 94.4b) / Total Assets 464b |
| B: 1.04 (Retained Earnings 482b / Total Assets 464b) |
| C: 0.07 (EBIT TTM 33.4b / Avg Total Assets 458b) |
| D: 1.25 (Book Value of Equity 254b / Total Liabilities 203b) |
| Altman-Z'' = 5.24 = AAA |
| DSRI: 1.39 (Receivables 61.8b/46.3b, Revenue 326b/340b) |
| GMI: 0.88 (GM 22.45% / 25.49%) |
| AQI: 0.97 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 0.96 (Revenue 326b / 340b) |
| TATA: -0.05 (NI 25.3b - CFO 47.7b) / TA 464b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 137.46 with a total of 13,988,117 shares traded. Over the past week, the price has changed by +0.87%, over one month by -7.69%, over three months by -10.74% and over the past year by +24.64%.
Current recommended Stop Loss: 132.50 (which is 3.6% or 1.5 ATR below the current price).
Exxon Mobil has received a consensus analysts rating of 3.93. Therefore, it is recommended to buy XOM.
- StrongBuy: 10
- Buy: 7
- Hold: 10
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 170.3 | 23.9% |
P/E Trailing = 23.0791
P/E Forward = 12.0337
P/S = 1.743
P/B = 2.2206
P/EG = 1.1251
Revenue TTM = 326b USD
EBIT TTM = 33.4b USD
EBITDA TTM = 60.4b USD
Long Term Debt = 33.1b USD (from longTermDebt, last quarter)
Short Term Debt = 14.5b USD (from shortTermDebt, last quarter)
Debt = 54.0b USD (from shortLongTermDebtTotal, last quarter) + Leases 6.31b
Net Debt = 45.5b USD (calculated: Debt 54.0b - CCE 8.44b)
Enterprise Value = 614b USD (568b + Debt 54.0b - CCE 8.44b)
Interest Coverage Ratio = 48.16 (Ebit TTM 33.4b / Interest Expense TTM 693.0m)
EV/FCF = 32.66x (Enterprise Value 614b / FCF TTM 18.8b)
FCF Yield = 3.06% (FCF TTM 18.8b / Enterprise Value 614b)
FCF Margin = 5.76% (FCF TTM 18.8b / Revenue TTM 326b)
Net Margin = 7.76% (Net Income TTM 25.3b / Revenue TTM 326b)
Gross Margin = 25.49% ((Revenue TTM 326b - Cost of Revenue TTM 243b) / Revenue TTM)
Gross Margin QoQ = 37.71% (prev 18.89%)
Tobins Q-Ratio = 1.32 (Enterprise Value 614b / Total Assets 464b)
Interest Expense / Debt = 1.28% (Interest Expense 693.0m / Debt 54.0b)
Taxrate = 28.48% (10.4b / 36.6b)
NOPAT = 23.9b (EBIT 33.4b * (1 - 28.48%))
Current Ratio = 1.04 (Total Current Assets 97.8b / Total Current Liabilities 94.4b)
Debt / Equity = 0.21 (Debt 54.0b / totalStockholderEquity, last quarter 254b)
Debt / EBITDA = 0.75 (Net Debt 45.5b / EBITDA 60.4b)
Debt / FCF = 2.42 (Net Debt 45.5b / FCF TTM 18.8b)
Total Stockholder Equity = 259b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.53% (Net Income 25.3b / Total Assets 464b)
RoE = 9.77% (Net Income TTM 25.3b / Total Stockholder Equity 259b)
RoCE = 11.42% (EBIT 33.4b / Capital Employed (Equity 259b + L.T.Debt 33.1b))
RoIC = 6.35% (NOPAT 23.9b / Invested Capital 376b)
WACC = 6.08% (E(568b)/V(622b) * Re(6.57%) + D(54.0b)/V(622b) * Rd(1.28%) * (1-Tc(0.28)))
Discount Rate = 6.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 2.33 | Cagr: 1.89%
[DCF] Terminal Value 73.10% ; FCFF base≈22.5b ; Y1≈19.8b ; Y5≈16.0b
[DCF] Fair Price = 50.88 (EV 256b - Net Debt 45.5b = Equity 211b / Shares 4.14b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -95.97 | EPS CAGR: -18.99% | SUE: 3.38 | # QB: 1
Revenue Correlation: -79.24 | Revenue CAGR: -2.84% | SUE: -0.42 | # QB: 0
EPS current Quarter (2026-06-30): EPS=3.73 | Chg30d=+0.17% | Revisions=+10% | Analysts=17
EPS next Quarter (2026-09-30): EPS=3.40 | Chg30d=-1.62% | Revisions=+10% | Analysts=16
EPS current Year (2026-12-31): EPS=11.29 | Chg30d=+0.44% | Revisions=+53% | GrowthEPS=+61.6% | GrowthRev=+21.0%
EPS next Year (2027-12-31): EPS=10.81 | Chg30d=+1.48% | Revisions=+52% | GrowthEPS=-4.3% | GrowthRev=-5.0%
[Analyst] Revisions Ratio: +45% (up=34, down=12)